TJM Labs · B2B · AI agents for pharmacies
Set your valuation from public company multiples and a bottom-up forecast
Raised at over 15x ARR
Workedfinancing
What they did
Looks at public companies' revenue multiples vs growth (Figma ~10-15x at ~40% growth; growing 10x should be no less than 15x). With Elephant, did napkin math on a path to $100M ARR: 450 pharmacies today of ~16,000, going to 1,000 then 3,000, and checked the valuation holds if they execute and the plan is realistic. Warns that too high a valuation comes back to bite.
What happened
Raised at greater than 15x ('easily')
Related topics
Get tactics like this every Monday
New tactics from the week's founder interviews, each linked to where it was said.
More from this episode
- TJM Labs: Build your first version for one desperate customer you already knowBecame a $1M+ a year customer; sole customer for 9 months
- TJM Labs: Price each AI agent per year, just under one employee's salary$45K per agent a year; pharmacies average 2.5-3 agents
- TJM Labs: Let happy customers bring in their friends before hiring a sales team~30 pharmacies through customer referrals alone
- TJM Labs: Use LinkedIn as your main outbound sales channelFounder says the team does great work there; no numbers
- TJM Labs: Sell AI agents as a replacement for hired staff, not as softwareFounder says small pharmacies go from 2% to 8% margins
- TJM Labs: Buy small companies in your space mainly to get their teamsUnder 5% of growth came from the deals; bought for the team
- TJM Labs: Announce your funding round to make hiring easierFounder says it makes hiring talks a lot easier; no numbers
- TJM Labs: Raise money while profitable, before you need it$100M raised in ~6 months at 40% EBITDA, with no pitch deck
- Galen AI: Turn a problem you keep solving as a consultant into a productBootstrapped; acquired after ~1.5 years, soon after its first enterprise customer